RetinalGenix Technologies Ratios (2020-2026) | RTGN

Ratios Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter)
0.02M0.00M0.00M0.00M0.00M0.00M0.00M0.00M190.500.03M0.07M0.09M0.05M0.01M0.01M0.01M0.01M0.01M
Equity Average (Quarter)
-0.15M-0.22M-0.44M-0.59M-0.70M-0.87M-1.06M-1.29M-1.64M-1.43M-1.24M-1.46M-1.67M-1.83M-1.66M-1.57M-1.82M-2.08M-2.24M-2.43M
Invested Capital (Quarter)
-0.04M-0.25M-0.39M-0.65M-0.60M-1.01M-1.02M-1.45M-1.73M-1.08M-1.36M-1.47M-1.76M-1.81M-1.41M-1.62M-1.93M-2.12M-2.25M-2.56M
Leverage & Solvency
Debt to Equity (Quarter)
-0.40-0.16-0.10-0.11-0.05-0.05-0.03-0.03-0.03-0.03-0.03-0.03-0.03-0.03-0.02-0.02-0.02
Debt Ratio (Quarter)
4.4914.7628.570.00M12.26166.676.3623.12314.100.970.560.553.284.115.847.002.33
Equity Ratio (Quarter)
-11.28-93.93-283.49-0.03M-270.56-0.00M-194.94-837.58-0.00M-0.01M-30.06-20.82-20.87-97.86-139.80-236.19-310.35-109.43-440.67
Valuation
Enterprise Value (Quarter)
-0.04M-0.00M-0.00M-27.00-0.00M-38.00-0.01M-0.00M-44.00-0.05M-0.09M-0.08M-0.01M-0.00M-839.00-92.00-0.01M-180.00